Recurrent activating mutations of PPARγ associated with luminal bladder tumors
Natacha Rochel(Centre National de la Recherche Scientifique), Isabelle Bernard‐Pierrot(Institut Curie)
Cited by 73
Related Papers
An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
|EMBO Molecular Medicine|2018|90
Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia
|Nature Communications|2021|52
Mechanism of Inhibition of the MeTC7 Ligand That Covalently Binds to VDR To Reduce PD-L1 Expression
|Journal of Medicinal Chemistry|2025|1